Home
Black men in the U.S. are more likely to be diagnosed with and to die from prostate cancer vs. men of other backgrounds. They are diagnosed at a younger age and with more advanced disease. Yet, Black men remained a footnote in national prostate cancer screening guidelines. These new guidelines represent a first step in closing the gaps in prostate health and prostate cancer care for Black men.
Read MoreBlack men in the U.S. are more likely to be diagnosed with and to die from prostate cancer vs. men of other backgrounds. They are diagnosed at a younger age and with more advanced disease. Yet, Black men remained a footnote in national prostate cancer screening guidelines. These new guidelines represent a first step in closing the gaps in prostate health and prostate cancer care for Black men.
Read MoreMedical oncologist Alicia Morgans, MD, MPH (Dana Farber) hosts a discussion with nurse practitioner Stacy Walker, CNP, and social worker Max McMahon, LICSW. Learn about the members of your care team, and how they handle patients’ most common and challenging questions.
Learn More and RegisterThe Prostate Cancer Foundation would like to thank Dr. Collins for going public with his prostate cancer diagnosis, spurring men and families to talk about prostate cancer and to understand its urgency.
Read MoreMore than 9,000 clinicians and researchers gathered at the 2024 European Association of Urology Annual Congress to share the latest research findings. These meetings are important because, ultimately, many of these developments will eventually improve patient care.
Watch the VideoPCF Challenge Awards fund international, multi-institutional, cross-disciplinary teams of investigators conducting highly innovative research. Following a rigorous peer review process that assessed each project’s scientific merit and potential patient impact, 20 highly coveted PCF Challenge Awards were granted to teams at some of the world’s leading cancer research institutions.
Read MoreOur new partnership with FreeWill is a free, secure, online tool that simplifies creating a will, making it an easy task for anyone. This valuable new resource that not only eases the process of estate planning but also helps support prostate cancer research. We invite you to explore this resource and take that important step toward securing your future.
Learn MoreMovember is partnering with the ICECaP Consortium to leverage the natural alignment of our shared goal to accelerate global progress on a strategic approach that can significantly reduce the number of men dying from prostate cancer.
Learn MoreWe are in a race for patients. For your husbands and fathers. For your sons ... and now your daughters.
A PCF-funded study published in the prestigious journal Science has identified a new subtype of castration-resistant prostate cancer (CRPC). Understanding how genes and proteins “drive” this particular type of cancer may lead to new treatments. In...
Advanced Prostate CancerFrom the Lab“Plant-based” foods are increasingly on the radar. You can grab a green juice at most chain coffee shops, a decent salad at airport restaurants, or a meat-free veggie burger at some locations of the major burger...
DietNutritionAs men age, their testosterone levels can fall: by one estimate, 39% of men aged 45-85 have blood testosterone levels considered low (less than 300 ng/mL). Many have no symptoms, but some men may experience symptoms...
Questions for Your Treatment TeamSexual HealthSnapshot of Cancer Metastatic prostate cancer looks a lot different from cancer that is confined to the prostate. That’s because over time, as it develops the ability to spread beyond the prostate, cancer undergoes specific mutations....
Receive PCF news in your inbox
If you’ve recently been diagnosed with prostate cancer, you may be asking yourself if there were warning signs or symptoms you should have noticed earlier. So...
In 1993, PCF created a Competitive Awards program that revolutionized the evaluation and funding of prostate cancer research. Fortune magazine credited PCF with creating the “modern venture philanthropy” model for cancer research—citing the transformative power of PCF’s short grant applications and rapid funding. The awards empowered many young scientists to fill the pipeline...
For ResearchersThe Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization dedicated to funding life-saving prostate cancer research. Founded in 1993 by Mike Milken, PCF has been responsible for raising more than $1 billion in support of cutting-edge research through more than 2,250 research projects at 245 leading cancer centers, with a global footprint spanning 28 countries. Since PCF’s inception, and through its efforts, patients around the world are living longer, suffering fewer complications, and enjoying better quality of life. PCF is committed to the mission of ending death and suffering from the disease.
Learn more about our foundation